Research Summary
Neuromodulation is a medical technique that involves the alteration of nerve activity through targeted delivery of electrical or pharmaceutical agents to specific neurological sites in the body. It is used to treat a variety of conditions, including chronic pain, movement disorders, and psychiatric conditions, by modulating the activity of neurons and neural circuits. Methods of neuromodulation include spinal cord stimulation, deep brain stimulation, and transcranial magnetic stimulation, among others. These interventions can help restore normal function, alleviate symptoms, and improve the quality of life for patients with otherwise difficult-to-treat neurological conditions.
According to DIResearch's in-depth investigation and research, the global Neuromodulation market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Neuromodulation include Medtronic, Boston Scientific Corporation, Abbott, LivaNova, Synapse Biomedical, Inc., Nevro Corporation, NeuroSigma, NeuroPace, Neuronetics, BioControl Medical etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Neuromodulation. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Neuromodulation market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Neuromodulation market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Neuromodulation industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Neuromodulation Include:
Medtronic
Boston Scientific Corporation
Abbott
LivaNova
Synapse Biomedical, Inc.
Nevro Corporation
NeuroSigma
NeuroPace
Neuronetics
BioControl Medical
Neuromodulation Product Segment Include:
Internal Treatment
External Treatment
Neuromodulation Product Application Include:
Ischemia
Chronic Pain
Parkinson's
Depression
Tremor
Epilepsy
Migraine
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Neuromodulation Industry PESTEL Analysis
Chapter 3: Global Neuromodulation Industry Porter's Five Forces Analysis
Chapter 4: Global Neuromodulation Major Regional Market Size and Forecast Analysis
Chapter 5: Global Neuromodulation Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Neuromodulation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Neuromodulation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Neuromodulation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Neuromodulation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Neuromodulation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Neuromodulation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Neuromodulation Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Neuromodulation Market Overview 1.1 Product Definition and Statistical Scope 1.2 Neuromodulation Product by Type 1.2.1 Global Neuromodulation Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Internal Treatment 1.2.3 External Treatment 1.3 Neuromodulation Product by Application 1.3.1 Global Neuromodulation Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Ischemia 1.3.3 Chronic Pain 1.3.4 Parkinson's 1.3.5 Depression 1.3.6 Tremor 1.3.7 Epilepsy 1.3.8 Migraine 1.4 Global Neuromodulation Market Revenue Analysis (2019-2030) 1.5 Neuromodulation Market Development Status and Trends 1.5.1 Neuromodulation Industry Development Status Analysis 1.5.2 Neuromodulation Industry Development Trends Analysis 2 Neuromodulation Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Neuromodulation Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Neuromodulation Market Analysis by Regions 4.1 Neuromodulation Overall Market: 2023 VS 2024 VS 2030 4.2 Global Neuromodulation Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Neuromodulation Revenue and Market Share by Region (2019-2024) 4.2.2 Global Neuromodulation Revenue Forecast by Region (2025-2030) 5 Global Neuromodulation Market Size by Type and Application 5.1 Global Neuromodulation Market Size by Type 5.2 Global Neuromodulation Market Size by Application 6 North America 6.1 North America Neuromodulation Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Neuromodulation Market Size by Type 6.4 North America Neuromodulation Market Size by Application 6.5 North America Neuromodulation Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Neuromodulation Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Neuromodulation Market Size by Type 7.4 Europe Neuromodulation Market Size by Application 7.5 Europe Neuromodulation Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Neuromodulation Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Neuromodulation Market Size by Type 8.4 China Neuromodulation Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Neuromodulation Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Neuromodulation Market Size by Type 9.4 APAC (excl. China) Neuromodulation Market Size by Application 9.5 APAC (excl. China) Neuromodulation Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Neuromodulation Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Neuromodulation Market Size by Type 10.4 Latin America Neuromodulation Market Size by Application 10.5 Latin America Neuromodulation Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Neuromodulation Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Neuromodulation Market Size by Type 11.4 Middle East & Africa Neuromodulation Market Size by Application 11.5 Middle East & Africa Neuromodulation Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Neuromodulation Market Revenue by Key Manufacturers (2020-2024) 12.2 Neuromodulation Competitive Landscape Analysis and Market Dynamic 12.2.1 Neuromodulation Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Medtronic 13.1.1 Medtronic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Medtronic Neuromodulation Product Portfolio 13.1.3 Medtronic Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Boston Scientific Corporation 13.2.1 Boston Scientific Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Boston Scientific Corporation Neuromodulation Product Portfolio 13.2.3 Boston Scientific Corporation Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Abbott 13.3.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Abbott Neuromodulation Product Portfolio 13.3.3 Abbott Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 LivaNova 13.4.1 LivaNova Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 LivaNova Neuromodulation Product Portfolio 13.4.3 LivaNova Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Synapse Biomedical, Inc. 13.5.1 Synapse Biomedical, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Synapse Biomedical, Inc. Neuromodulation Product Portfolio 13.5.3 Synapse Biomedical, Inc. Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Nevro Corporation 13.6.1 Nevro Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Nevro Corporation Neuromodulation Product Portfolio 13.6.3 Nevro Corporation Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 NeuroSigma 13.7.1 NeuroSigma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 NeuroSigma Neuromodulation Product Portfolio 13.7.3 NeuroSigma Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 NeuroPace 13.8.1 NeuroPace Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 NeuroPace Neuromodulation Product Portfolio 13.8.3 NeuroPace Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Neuronetics 13.9.1 Neuronetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Neuronetics Neuromodulation Product Portfolio 13.9.3 Neuronetics Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 BioControl Medical 13.10.1 BioControl Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 BioControl Medical Neuromodulation Product Portfolio 13.10.3 BioControl Medical Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Neuromodulation Industry Chain Analysis 14.2 Neuromodulation Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Neuromodulation Typical Downstream Customers 14.4 Neuromodulation Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support